Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28343864 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15HSD17B10CYP2C9 | |
| Hydrochloric Acid SCHEMBL2869919 | 0.98 | ALDH1A1 (0.48) | ALDH1A1TSHRALOX15HSD17B10CYP2C9 | |
| SCHEMBL24478531 | 0.94 | MAPT (0.45) | ALDH1A1TSHRALOX15HSD17B10CYP2C9 | |
| SCHEMBL19319170 | 0.94 | SLC2A1 (0.53) | ALDH1A1TSHRALOX15HSD17B10CYP2C9 | |
| SCHEMBL598140 | 0.83 | ALDH1A1 (0.52) | ALDH1A1TSHRALOX15HSD17B10CYP2C9 | |
| SCHEMBL17428470 | 0.80 | CNR2 (0.50) | ALDH1A1TSHRCYP2C9CYP3A4MAPK1 | |
| SCHEMBL14236881 | 0.80 | CYP2C9 (0.44) | ALDH1A1TSHRALOX15HSD17B10CYP2C9 | |
| SCHEMBL13955431 | 0.80 | ALDH1A1 (0.48) | ALDH1A1TSHRALOX15HSD17B10CYP3A4 | |
| SCHEMBL14325874 | 0.80 | CYP2C9 (0.44) | ALDH1A1TSHRALOX15HSD17B10CYP2C9 | |
| SCHEMBL8170432 | 0.79 | ALDH1A1 (0.52) | ALDH1A1TSHRALOX15HSD17B10CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250107971-A1 | POWDER-LIQUID-TYPE DENTAL PLATE LINER | TOKUYAMA DENTAL CORPORATION (JP) | 2025-04-03 | — | — | US | disclosed |
| EP-4464302-A1 | POWDER-LIQUID-TYPE DENTURE BASE LINER | Tokuyama Dental Corporation (JP) | 2024-11-20 | — | — | EP | disclosed |
| WO-2023135930-A1 | POWDER-LIQUID-TYPE DENTURE BASE LINER | 株式会社トクヤマデンタル | 2023-07-20 | — | — | WO | disclosed |
| US-11697648-B2 | Fused pyrimidine pyridinone compounds as JAK inhibitors | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2023-07-11 | — | — | US | disclosed |
| CN-110655456-B | Method for preparing chiral alkyl compound by asymmetric catalytic hydrogenation of E/Z mixed or single-configuration tri-substituted olefin | 浙江大学 | 2020-11-24 | — | — | CN | disclosed |
| WO-2020150385-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS | CURZA GLOBAL, LLC (US) | 2020-07-23 | — | — | WO | disclosed |
| CN-110655456-A | Method for preparing chiral alkyl compound by asymmetric catalytic hydrogenation of E/Z mixed or single-configuration tri-substituted olefin | 浙江大学 | 2020-01-07 | — | — | CN | disclosed |
| US-10457823-B2 | Aqueous ink composition, ink set, image forming method, and resin microparticles | FUJIFILM CORPORATION (JP) | 2019-10-29 | — | — | US | disclosed |
| US-20180142117-A1 | SWITCHABLE WATER-BASED PAINT OR COATING COMPOSITIONS | GREENCENTRE CANADA (CA) | 2018-05-24 | — | — | US | disclosed |
| US-20170362452-A1 | AQUEOUS INK COMPOSITION, INK SET, IMAGE FORMING METHOD, AND RESIN MICROPARTICLES | FUJIFILM CORPORATION (JP) | 2017-12-21 | — | — | US | disclosed |
| CN-101341176-B | Ethylene polymer, catalyst for producing ethylene polymer, and method for producing ethylene polymer | TOSOH CORP | 2011-08-17 | — | — | CN | disclosed |
| US-20100227076-A1 | INK COMPOSITION AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2010-09-09 | — | — | US | disclosed |
| CN-101341176-A | Ethylene polymer, catalyst for producing ethylene polymer, and method for producing ethylene polymer | TOSOH CORP (JP) | 2009-01-07 | — | — | CN | disclosed |
| EP-0942006-B1 | Catalyst for olefin polymer production and process for olefin polymer production employing the catalyst | TOSOH CORP (JP) | 2003-06-04 | — | — | EP | disclosed |
| EP-0849292-B1 | Olefin polymerisation catalysts and processes for producing olefin polymers | TOSOH CORP (JP) | 2002-08-21 | — | — | EP | disclosed |
| US-6372681-B1 | METALLOCENE OF TRANSITION METAL AND; METAL OXIDE, SULFIDE, PHOSPHIDE, CARBIDE, NITRIDE, AND/OR SELENIDE; ORGANOALKALINE EARTH OR ZINC COMPOUND; AND ORGANOALUMINUM COMPOUND | TOSOH CORPORATION (JP) | 2002-04-16 | — | — | US | disclosed |
| US-6337297-B1 | CHROMIUM CATALYST FOR TRIMERIZATION OF ETHYLENE WITH MULTIDENTATE LIGAND OR HALOGEN, CARBOXY GROUP | TOSOH CORPORATION (JP) | 2002-01-08 | — | — | US | disclosed |
| US-6110858-A | AN OLEFIN POLYMERIZATION CATALYST CONSISTS OF A TRANSITION METAL COMPOUND, A MODIFIED CLAY COMPOUND CONTAINING CLAY MINERAL AND AN AMINE COMPOUND AND AN ORGANOALUMINUM COMPOUND | TOSOH CORPORATION (JP) | 2000-08-29 | — | — | US | disclosed |
| EP-0942006-A2 | Catalyst for olefin polymer production and process for olefin polymer production employing the catalyst | TOSOH CORPORATION (JP) | 1999-09-15 | — | — | EP | disclosed |
| EP-0849292-A1 | Olefin polymerisation catalysts and processes for producing olefin polymers | TOSOH CORPORATION (JP) | 1998-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250107971-A1 | POWDER-LIQUID-TYPE DENTAL PLATE LINER | HEATR1, HEATR6, ACTR5 | ALDH1A1 2486/4885TSHR 1220/4885ALOX15 634/4885 |
| US-11697648-B2 | Fused pyrimidine pyridinone compounds as JAK inhibitors | JAK3, JAK1, JAK2 | ALDH1A1 2446/4885TSHR 3007/4885ALOX15 1971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.